HDAC-IN-52

Overview

HDAC-IN-52 is a pyridine-containing HDAC inhibitor, with IC 50 s of 0.189, 0.227, 0.440 and 0.446 μM for HDAC1 , HDAC2 , HDAC3 , and HDAC10 , respectively. HDAC-IN-52 can be used for the research of cancer .

Application

Products | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Liver Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > HDAC

Product Information

• Catalog No.: HY-152174
• CAS No.: 2075787-77-6
• Molecular Formula: C24H20N4O2
• Molecular Weight: 396.44
• Purity: 99.46%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Availability: In-stock

Source

Original product source